罗欣药业(002793) - 2018 Q4 - 年度财报

Financial Performance - The company's operating revenue for 2018 was approximately ¥935.45 million, representing a 12.97% increase compared to ¥828.04 million in 2017[16]. - The net profit attributable to shareholders for 2018 was approximately ¥111.35 million, a decrease of 3.89% from ¥115.85 million in 2017[16]. - The net profit after deducting non-recurring gains and losses was approximately ¥105.61 million, down 4.40% from ¥110.47 million in 2017[16]. - The total revenue for the year reached ¥935,445,820.67, representing a year-on-year growth of 12.97%[33]. - The net profit attributable to shareholders for the year was ¥111,345,642.47, which marked a decline of 3.89% compared to the previous year[33]. - The basic earnings per share for 2018 was ¥0.56, a decrease of 3.45% from ¥0.58 in 2017[16]. - The diluted earnings per share for 2018 was ¥0.54, down 6.90% from ¥0.58 in 2017[17]. - The weighted average return on equity for 2018 was 13.67%, a decrease of 2.50% from 16.17% in 2017[17]. Cash Flow and Assets - The net cash flow from operating activities increased by 9.20% to approximately ¥114.12 million, compared to ¥104.51 million in 2017[16]. - The company's cash and cash equivalents increased by ¥196,706,625.22, a significant rise of 1,298.58%[52]. - The net cash flow from operating activities was ¥114,115,186.36, reflecting a 9.20% increase year-on-year[51]. - The total assets at the end of 2018 were approximately ¥1.40 billion, a 55.93% increase from ¥898.93 million at the end of 2017[17]. - The net assets attributable to shareholders at the end of 2018 were approximately ¥909.89 million, up 20.64% from ¥754.19 million at the end of 2017[17]. - The total amount of fixed assets decreased by 8.66% to ¥197,113,837[54]. Production and Capacity - The company produced 190.39 thousand submersible pumps in 2018, a 19.02% increase compared to 159.96 thousand in 2017[43]. - The company's production capacity utilization rate is currently at 102.9%, with a project underway to increase annual production capacity to 2 million submersible pumps, which will alleviate current capacity constraints[35]. - The company is currently constructing a project with an annual production capacity of 200,000 submersible pumps, aimed at overcoming production capacity constraints[30]. - The company has invested CNY 101,229,942.06 in advance for the annual production project of 2 million submersible pumps, which has been verified by an accounting firm[74]. Research and Development - The company holds 59 patents and has developed high-tech products such as corrosion-resistant submersible pumps, showcasing its strong R&D capabilities[28]. - Research and development expenses amounted to ¥33,353,721.78, representing 3.57% of operating revenue[49]. - The R&D expenditure for new product development was RMB 50 million, accounting for 5% of total revenue[97]. - The company aims to strengthen its research and development capabilities to adapt to market demands and improve innovation[75]. Market Presence and Sales - The company has established long-term stable partnerships with over 100 clients across Africa, Asia, and Europe, enhancing its market presence[26]. - Revenue from the African market decreased slightly by 0.77% to CNY 236.70 million, while revenue from the Asian market increased by 24.93% to CNY 434.46 million[39]. - The company's main product, submersible pumps, accounted for 78.41% of total revenue in 2018, with sales revenue reaching approximately CNY 724.26 million, a year-on-year increase of 9.95%[35]. - The company aims to strengthen its brand presence globally while expanding its domestic market share to become a significant player in the submersible pump industry[34]. Dividend and Shareholder Information - The company plans to distribute a cash dividend of ¥3.00 per 10 shares to all shareholders[4]. - The cash dividend distribution represents 100% of the total profit distribution amount, with no stock dividends or capital reserve transfers planned for the year[87]. - The company reported a net profit of 67,383,726.90 yuan for the year, with a distribution ratio of 60.52% to ordinary shareholders[86]. - The company has a history of cash dividend distributions, with the 2016 distribution being 6.00 yuan (including tax) for every 10 shares, totaling 60,000,000.00 yuan (including tax)[82]. Compliance and Governance - The company has normal compliance with all commitments made during the IPO and refinancing processes[91]. - The company has established a clear framework for share reduction and management to ensure stability and compliance with regulations[92]. - The company has committed to ensuring the protection of investors' legal rights and interests through strict compliance with legal obligations[110]. - The company has maintained a continuous relationship with Tianjian Accounting Firm for six years, paying an audit fee of 600,000 CNY for the current year[127]. Strategic Plans and Future Outlook - The company plans to expand its market presence by entering three new provinces in 2019, aiming for a 20% increase in market share[96]. - The company aims for a revenue growth target of 12% for 2019, projecting total revenue of approximately 1.344 billion RMB[177]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of up to RMB 200 million allocated for potential targets[98]. - A new product line is expected to launch in Q2 2019, projected to contribute an additional RMB 100 million in revenue[97].